Your browser doesn't support javascript.
loading
Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
Quintela-Fandino, Miguel; López, Joaquín Martínez; Hitt, Ricardo; Gamarra, Soledad; Jimeno, Antonio; Ayala, Rosa; Hornedo, Javier; Guzman, Cecilia; Gilsanz, Florinda; Cortés-Funes, Hernán.
Affiliation
  • Quintela-Fandino M; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain. quintelamiguel2000@yahoo.es
J Clin Oncol ; 24(22): 3611-8, 2006 Aug 01.
Article in En | MEDLINE | ID: mdl-16877728
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / RNA Precursors / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Peripheral Blood Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2006 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / RNA Precursors / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Peripheral Blood Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2006 Document type: Article